Navigation Links
Lilly Again Named One of DiversityInc's Top 50 Companies for Diversity
Date:4/24/2013

ve stock performance."

Both the 2013 and the 2012 DiversityInc Top 50 lists outperformed the S&P 500 on a one-, three- and five-year basis.

Hawkins said Lilly's work to continuously improve inclusiveness has led to many successes in the United States and at its global affiliates.

Many of the programs are focused on female representation and leadership, which have been noted as areas of strength for Lilly by DiversityInc.  Previous evaluations of Lilly have spotlighted the company's success in the representation of women at top management levels and the promotion rate of women into management and within management ranks.

Lilly also has received several honors for its workplace initiatives involving women. Key awards include:

  • 2020 Women on Boards Winning Company for having over 20 percent of the board of directors female (Lilly's is 29 percent)
  • Working Mother magazine Hall of Fame; Lilly has been on the Working Mothers list for 17 consecutive years
  • Top Companies for Executive Women (NAFE) list since 2009

DiversityInc also has indicated Lilly's talent development programs and pipeline for other under-represented groups are showing results. Additional organizations have honored Lilly for these programs. The honors include:

  • LATINO 100 top companies offering opportunities for Latinos,
  • Human Rights Campaign Best Places to Work Corporate Equality Index, perfect score
  • Best in Class Employers of Asian Pacific American Professionals Finalist

DiversityInc Methodology

The results are determined by statistical analysis. It is an independent editorial process and there is no fee to enter the competition and no requirement to conduct business with DiversityInc.

DiversityInc 201
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DiversityInc Names Lilly a Top Company for Diversity
2. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
3. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
4. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
5. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
6. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
7. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
8. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
9. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
10. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
11. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2013 through 2020. Also, a ...
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report ... Animals. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:9/16/2014)... , Sept. 16, 2014  ROX Medical ... an international multi-center, prospective, randomized, controlled, blinded endpoint ... of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the ... a fixed connection between a central artery and ... treatment of hypertension. The primary outcomes are reduction ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11
(Date:9/16/2014)... Pulmonary Hypertension Association Travels to San Diego for PHA ... and Families to Help Fight Rare Lung Disease , Who:, ... hypertension association that works to find ways to prevent and ... that affects the functioning of the heart and can lead ... 2.8 years. , What:, PHA On The Road ...
(Date:9/16/2014)... Doheny HealthDay Reporter TUESDAY, ... can routinely spot human papillomavirus (HPV), which is linked to ... "Our study shows that testing urine for HPV has good ... for HPV," said lead researcher Dr. Neha Pathak. She is ... Queen Mary University of London, England. The test could ...
(Date:9/16/2014)... Cliff Lake Dental Care is proud to announce ... dental hygienist to join Dr. Rauchwarter's team. The team at ... and knows she will bring many benefits to the office ... in River Falls, WI. She finished dental assisting school ... practiced dental assisting in the Twin Cities, Milwaukee, California and ...
(Date:9/16/2014)... 2014 Aspen Advisors, a U.S.-based healthcare ... recognized for its high morale and collaborative culture ... Small Firms to Work For 2014.” Consulting magazine ... than 10,000 consultants participating across all major industries, representing ... were conducted, and firms were ranked in six categories ...
(Date:9/16/2014)... Treatment with endocrine therapy and radiation therapy as ... of care for women with hormone-receptor positive (HR+) ... at Fox Chase Cancer Center, however, shows that ... populations with the disease. , The results, ... Society for Radiation Oncology,s 56th Annual Meeting on ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3
... HARBIN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... CSKI ), a,leading fully integrated pharmaceutical company ... today announced the launch of,its new corporate website under ... The new website features an expanded ...
... 11 An insidious illness is stealing the vitality of ... closely mirror those of other conditions, it is frequently misdiagnosed, ... know they could prevent the condition, known as systemic Candida, ... Now Kathleen Kalaf, founder and president of the non-profit ...
... localized disease, research shows , TUESDAY, Aug. 11 ... in advanced prostate cancer patients but doesn,t reduce the ... researchers say. , They reported on the long-term survival ... trials launched in 1994. The trials examined the effects ...
... ... a two year partnership with XtremeSportsID™. The NBCF edition of the interactive emergency identification ... fulfill the NBCF mission to save lives through early detection and awareness. , ... Lahaina, HI (PRWEB) August ...
... , BALTIMORE, Aug. 11 , , To ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NY59748LOGO ) , , News Facts ... created an engaging, first-of-its-kind Web-based series called the L e ... journalist Carol Martin . The resource brings together medical doctors, nurses, psychologists, ...
... , RESEARCH TRIANGLE PARK, N.C., Aug. 11 ... today announced the completion of a $16.1 million Series E ... Alta Partners, Sanderling Ventures and Asset Management Company participated in ... Proceeds from the financing will primarily be used to expand ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Launches New Corporate Website 2Health News:China Sky One Medical, Inc. Launches New Corporate Website 3Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 2Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 3Health News:Oral Drug Ups Survival in Advanced Prostate Cancer Cases 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 2Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 4Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 5Health News:Chimerix Raises $16.1 Million in Series E Financing 2
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
... Liquichek ToRCH Plus IgM Controls ... problems in your ToRCH IgM ... your test results. Liquichek ToRCH ... perfect complement to Liquichek ToRCH ...
... Plus Control is a bilevel ... the performance of the most ... assays. A weak positive and ... to monitor the performance of ...
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests....
Medicine Products: